SYDNEY, AUSTRALIA / ACCESSWIRE / April 30, 2018 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Thursday, 31 May 2018 at 9:00 a.m. (Australian Eastern Standard Time)
NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM
Notice is given that the Annual General Meeting of shareholders of Parnell Pharmaceuticals Holdings Ltd (Company) will be held on:
Thursday 31 May 2018 at 9:00 a.m. (Australian Eastern Standard Time)
The meeting is to be held in person at the Company's headquarters: First Floor, Unit 4, 476 Gardners Road, Alexandria NSW, 2015, Australia.
For a link to the full Notice of Annual General Meeting and Explanatory Memorandum please click:
http://cdn.newswire.com/files/x/b7/99/d9ebf17258c5f344bf8ec84954c4.pdf
For a link to the full set of audited Financial Statements for the Year Ended December 31, 2017, please click:
http://cdn.newswire.com/files/x/e7/c5/6583f81366ce5a9a9bbd32ec2d18.pdf
_________________________________
30 April 2018
Dear Shareholder,
On behalf of the Board of Directors of Parnell Pharmaceuticals Holdings Limited (ACN 137 904 413) (Company), I invite you to join us at a General Meeting of shareholders (GM), which has been scheduled as follows:
Date: 31 May 2018 (AEST)
Time: 9:00 a.m. (AEST)
Venue: Held by physical attendance at: First Floor, Unit 4 Century Estate, 476 Gardeners Road, Alexandria, NSW, 2015
Outline of the items of business
At this GM, we will provide an opportunity for shareholders to consider the following item of business:
- the Company's financial statements and related documents;
- ratification of the appointment of the Company auditor;
- election of Mr Tony Hartnell as a director of the Company; and
- re-election of Dr. Alan Bell as a director of the Company.
Details of this item are contained in the enclosed Notice of GM and Explanatory Memorandum.
Voting at the meeting or by proxy
A proxy form accompanies the enclosed Notice of AGM. If you wish to attend the AGM in person, please bring a copy of the proxy form with you. Registration will be available from 8:30 a.m. (AEST) If you are unable to attend in person, I encourage you to appoint a proxy to vote on the resolutions contained in the Notice of AGM on your behalf, by completing and returning the enclosed proxy form. Details of how to submit the proxy form are included with the form.
If you have any difficulties placing your vote via proxy please do not hesitate to contact Brad McCarthy at brad.mccarthy@parnell.com or call +612 9667 4411.
On behalf of all of the Directors, we look forward to hearing from you at the GM.
Yours sincerely,
Alan Bell
Chairman
SOURCE: Parnell Pharmaceuticals Holdings Ltd
